The latest quarterly cash is $88.81 Million with a QoQ Growth of +48.12%. Cash and cash equivalents include currency, bank deposits, and highly liquid investments that can be quickly converted to cash.
Q2 FY2026 (2026-06-30).
Reported quarterly cash and cash equivalents; no daily interpolation. Q2 FY2026 (2026-06-30): $88.81M.
$88.81M
$88.81 Million
Q2 FY2026 · 2026-06-30
+48.12%
vs. $59.96M prior quarter
23
Quarters of data available
| Period | Cash | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $88.81M | +48.12% | +173.87% |
| Q1 FY2026Period end 2026-03-31 | $59.96M | +32.97% | +43.47% |
| Q4 FY2025Period end 2025-12-31 | $45.09M | +46.33% | +48.71% |
| Q3 FY2025Period end 2025-09-30 | $30.82M | -4.98% | -15.88% |
| Q2 FY2025Period end 2025-06-30 | $32.43M | -22.40% | -21.69% |
| Q1 FY2025Period end 2025-03-31 | $41.79M | +37.83% | -11.38% |
| Q4 FY2024Period end 2024-12-31 | $30.32M | -17.23% | -39.96% |
| Q3 FY2024Period end 2024-09-30 | $36.63M | -11.54% | -13.50% |
| Q2 FY2024Period end 2024-06-30 | $41.41M | -12.20% | +3.58% |
| Q1 FY2024Period end 2024-03-31 | $47.16M | -6.61% | +20.96% |
| Q4 FY2023Period end 2023-12-31 | $50.50M | +19.25% | +18.45% |
| Q3 FY2023Period end 2023-09-30 | $42.35M | +5.94% | +205.67% |
| Q2 FY2023Period end 2023-06-30 | $39.98M | +2.54% | +134.81% |
| Q1 FY2023Period end 2023-03-31 | $38.99M | -8.55% | +102.58% |
| Q4 FY2022Period end 2022-12-31 | $42.63M | +207.72% | +73.78% |
| Q3 FY2022Period end 2022-09-30 | $13.86M | -18.62% | -37.73% |
| Q2 FY2022Period end 2022-06-30 | $17.02M | -11.54% | -29.75% |
| Q1 FY2022Period end 2022-03-31 | $19.25M | -21.55% | +81.62% |
| Q4 FY2021Period end 2021-12-31 | $24.53M | +10.27% | +49.61% |
| Q3 FY2021Period end 2021-09-30 | $22.25M | -8.19% | N/A |
| Q2 FY2021Period end 2021-06-30 | $24.23M | +128.69% | N/A |
| Q1 FY2021Period end 2021-03-31 | $10.60M | -35.38% | N/A |
| Q4 FY2020Period end 2020-12-31 | $16.40M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
